Matching articles for "Zyplast"

Addendum: Dermal Fillers

   
The Medical Letter on Drugs and Therapeutics • July 16, 2007;  (Issue 1265)
Some Medical Letter consultants have suggested that our recent article on dermal fillers (Med Lett Drugs Ther 2007; 49:39) should have included stronger warnings about the risk of fillers that are not...
Some Medical Letter consultants have suggested that our recent article on dermal fillers (Med Lett Drugs Ther 2007; 49:39) should have included stronger warnings about the risk of fillers that are not biodegradable, such as Artefill. The polymethylmethacrylate (PMMA, the same material that makes up Plexiglas) beads in Artefill can over time, even with the best technique, cause foreignbody granulomas and hypertrophic scarring, which may require surgical removal. Granulomas and nodules have been especially frequent when Artefill was injected into the lips. Complications are less likely with hyaluronic acid products such as Hylaform, Juvéderm or Restylane.

Download U.S. English.
Med Lett Drugs Ther. 2007 Jul 16;49(1265):59 | Show Full IntroductionHide Full Introduction

Dermal Fillers

   
The Medical Letter on Drugs and Therapeutics • May 7, 2007;  (Issue 1260)
Several injectable products are available for soft tissue augmentation of wrinkles and folds. These fillers are often used in conjunction with botulinum toxin type A (Botox)...
Several injectable products are available for soft tissue augmentation of wrinkles and folds. These fillers are often used in conjunction with botulinum toxin type A (Botox) injections.
Med Lett Drugs Ther. 2007 May 7;49(1260):39-40 | Show Full IntroductionHide Full Introduction

An Injectable Hyaluronic Acid (Restylane) for Wrinkles

   
The Medical Letter on Drugs and Therapeutics • March 1, 2004;  (Issue 1177)
An injectable gel of hyaluronic acid (Restylane) has been approved by the FDA for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Manufactured by Q-Med AB, a Swedish...
An injectable gel of hyaluronic acid (Restylane) has been approved by the FDA for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Manufactured by Q-Med AB, a Swedish company, it has been used outside the US since 1996.
Med Lett Drugs Ther. 2004 Mar 1;46(1177):17-8 | Show Full IntroductionHide Full Introduction